ARAVIVE BIOLOGICS
Aravive Biologics is a clinical-stage biotechnology company that focuses on developing therapies that target important survival pathways for both solid tumors as well as hematologic malignancies.
ARAVIVE BIOLOGICS
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2008-12-10
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.aravive.com
Total Employee:
11+
Status:
Active
Contact:
(936) 355-1910
Email Addresses:
[email protected]
Total Funding:
95.1 M USD
Technology used in webpage:
IPv6 COVID-19 Vimeo Akamai Hosted
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-15 | Versartis | Versartis acquired by Aravive Biologics | N/A |
Investors List
BVF Partners
BVF Partners investment in Post-IPO Equity - Aravive Biologics
Eshelman Ventures
Eshelman Ventures investment in Post-IPO Equity - Aravive Biologics
Invus
Invus investment in Post-IPO Equity - Aravive Biologics
Eshelman Ventures
Eshelman Ventures investment in Post-IPO Equity - Aravive Biologics
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Aravive Biologics
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Aravive Biologics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-03 | Aravive Appoints Rudy Howard as Chief Financial Officer |
| 2022-03-22 | Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer |
Official Site Inspections
http://www.aravive.com Semrush global rank: 9.09 M Semrush visits lastest month: 445
- Host name: tube-server.com
- IP address: 193.141.60.62
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Aravive Biologics"
Aravive - Org Chart, Teams, Culture & Jobs | The Org
View Aravive's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Aravive Company Profile - Office Locations, Competitors ... - Craft
Feb 7, 2024 Aravive has 5 employees at their 1 location and $9.14 m in annual revenue in FY 2022. See insights on Aravive including office locations, competitors, revenue, financials, …See details»
Aravive Company Profile | Management and Employees List
Aravive Profile and History Aravive, Inc. is a clinical-stage oncology company developing transformative therapeutics designed to halt the progression of life-threatening diseases. …See details»
Aravive, Inc. Information - RocketReach
Aravive, Inc. is a Pharmaceuticals, Biotechnology Research, and Clinical Trials company located in Houston, Texas with $7 million in revenue and 32 employees. Find top employees, contact …See details»
Aravive | Advent Life Sciences
Aravive, Inc., is a clinical stage biotechnology company focused on developing new therapies that target important survival pathways for both solid tumors as well as hematologic malignancies. Our primary therapeutic focus is the GAS6 …See details»
Aravive CEO and Key Executive Team - Craft.co
Aravive's Chief Executive Officer, Director is Gail McIntyre. Other executives include Vinay Shah, Chief Financial Officer; Fred Eshelman, Chairman of the Board and 10 others. See the full …See details»
Aravive - Overview, News & Similar companies | ZoomInfo.com
Jun 21, 2023 View Aravive (www.aravive.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Aravive Biologics - Crunchbase Company Profile
Aravive Biologics is a clinical-stage biotechnology company that focuses on developing therapies that target important survival pathways.See details»
Aravive, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Aravive, Inc. is a clinical stage biotech firm that specializes in creating innovative therapies aimed at stopping the advancement of severe illnesses such as cancer and fibrosis. The company …See details»
Aravive Biologics, Inc. - Drug pipelines, Patents, Clinical trials ...
Mar 6, 2025 Explore Aravive Biologics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 1 literature, Disease Domain:Neoplasms ...See details»
Aravive, Inc. Company Profile | Houston, TX - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aravive, Inc. of Houston, TX. Get the latest business insights from Dun & Bradstreet.See details»
Aravive 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Aravive. Use the PitchBook Platform to explore the full profile.See details»
Aravive Announces Board Composition and Executive …
Apr 9, 2020 Aravive, Inc. (Nasdaq: ARAV) is a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, including …See details»
Aravive: Shareholders Board Members Managers and Company …
Jan 29, 2024 Aravive, Inc. is a clinical-stage oncology company. The Company is focused on developing treatments designed to halt the progression of life-threatening diseases, including …See details»
Aravive, Inc. - AnnualReports.com
Aravive, Inc. is a clinical-stage oncology company developing transformative therapeutics designed to halt the progression of life-threatening diseases. Aravive’s lead therapeutic, AVB …See details»
Aravive, weeks from liquidation, lays off 70% of its staff
Aug 22, 2023 The cash-strapped biotech has “several weeks” to find a partner or funding—and is laying off 70% of its staff to preserve what money it has left.See details»
Aravive, Inc. Company Profile & Data: stocks, market cap, financials ...
Company Profile of Aravive, Inc. with information on the company's activities, financials, digital presence, market capitalization, stocks and stock indices, …See details»
Aravive, weeks from liquidation, lays off 70% of its staff as it seeks ...
Nov 3, 2023 The vultures are circling Aravive. Still reeling from a phase 3 flop, the cash-strapped biotech has “several weeks” to find a partner or funding—and is laying off 70% of its staff to …See details»
Aravive Reports Fourth Quarter and Full Year 2022 Financial
Mar 15, 2023 Aravive Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates Company on Track for PROC Phase 3, Pivotal Trial Readout in …See details»
Aravive Announces $10 Million Registered Direct Offering
Mar 30, 2022 Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules March 30, 2022 08:00 ET | Source: Aravive, Inc. FollowSee details»